Cite
HARVARD Citation
Cid‐Silva, P. et al. (2017). Clinical Experience with the Integrase Inhibitors Dolutegravir and Elvitegravir in HIV‐infected Patients: Efficacy, Safety and Tolerance. Basic & clinical pharmacology & toxicology. 121 (5), pp. 442-446. [Online].